ROYAL BANK OF CANADA

Bank

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1000275 TORONTO, A6

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,578

+$6,575 QoQ

Shares Held

1,687

+168600.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 86 holders

Holding Since

Jun 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. SABS ranks #312 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,578	1,687	+168600.0%	Shares	Defined	2026-08-14
2026-03-31	$3	1	-83.3%	Shares	Defined	2026-05-15
2024-06-30	$18	6	0.0%	Shares	Defined	2024-11-06
2024-03-31	$27	6	-91.2%	Shares	Defined	2024-11-05
2023-12-31	$46	68	-98.7%	Shares	Defined	2024-02-14
2023-09-30	$3,208	5,094	-5.1%	Shares	Defined	2023-11-14
2023-06-30	$4,454	5,368	+11.4%	Shares	Defined	2023-08-14
2023-03-31	$2,120	4,820	0.0%	Shares	Defined	2023-05-15
2022-12-31	$2,843	4,820	-5.8%	Shares	Defined	2023-02-14
2022-09-30	$3,587	5,119	+6.2%	Shares	Defined	2022-11-14
2022-06-30	$6,989	4,820	0.0%	Shares	Defined	2022-08-15
2022-03-31	$18,123	4,820	+141.0%	Shares	Defined	2022-05-16
2021-12-31	$15,620	2,000	—	Shares	Defined	2022-02-14
2021-09-30 BCYP	—	37	+270.0%	Shares	Defined	2021-11-15
2021-06-30 BCYP	—	10	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.